Article Information
History
- July 5, 2021.
Article Versions
- Version 1 (December 2, 2020 - 07:12).
- Version 2 (December 12, 2020 - 00:01).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David M. Wiseman, PhD, MRPharmSa,*,
- Pierre Kory, MD, MPAb,
- Samir A Saidi, PhD, MB ChBc and
- Dan Mazzucco, PhD.d
- aSynechion, Inc., Dallas, TX, USA
- bAurora St. Luke’s Medical Center, Milwaukee, WI, USA. and Front Line Critical Care Alliance. pierrekory{at}icloud.com
- cCentral Clinic School, University of Sydney, Australia, sam.saidi{at}sydney.edu.au
- dThird Eye Associates, Cherry Hill, NJ, USA. dmazzucco{at}zsxmedical.com
- ↵*Address for correspondence: Dr. David Wiseman, Synechion, Inc., 18208 Preston Road, Suite D9-405, Dallas, 75252, synechion{at}aol.com, Telephone: 972 931 5596, Fax: 972 931 5476
Authorship Contributions DMW conceived of the study with additional input from PK and DM. Statistical analysis was performed by DMW and DM. DMW wrote the first draft of the manuscript and is overall study guarantor with contributions from PK, DM and SAS. SAS contributed to analysis. All authors reviewed, revised, and approved the manuscript.